# GEMSTONE (NCT05587374)

> Cadonilimab (PD-1/CTLA-4 Bispecific Blockade) and Chemoradiotherapy in Nasopharyngeal Carcinoma (GEMSTONE)

No report yet. It can be ordered.

## Registry

- Registry record: https://clinicaltrials.gov/study/NCT05587374
- Phase: PHASE3
- Status: ACTIVE_NOT_RECRUITING
- Sponsor: Sun Yat-sen University
- Conditions: Nasopharyngeal Carcinoma; Nasopharyngeal Cancer
- Interventions: Cadonilimab; Gemcitabine; Cisplatin; Intensity-modulated radiotherapy
- Enrollment: 490
- Primary outcome: Failure-free survival (FFS) in intention-to-treat population
- Primary outcome: Overall survival (OS) in intention-to-treat population

## Preliminary discovery

Commentary in our index that names this trial so far. Final coverage is set when the report is built.

- Bluesky threads: 2
- Podcasts: 1
- X threads: 1

## Order

Focused, $750, price fixed at order: https://www.erudio.com/contact?report=gemstone-nct05587374